Share-based Payment Arrangement, Expense in USD of CAPRICOR THERAPEUTICS, INC. from Q2 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
CAPRICOR THERAPEUTICS, INC. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q2 2011 to Q3 2025.
  • CAPRICOR THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $4M, a 94.9% increase year-over-year.
  • CAPRICOR THERAPEUTICS, INC. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $15.7M, a 68% increase year-over-year.
  • CAPRICOR THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2024 was $9.77M, a 32.1% increase from 2023.
  • CAPRICOR THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2023 was $7.39M, a 65.8% increase from 2022.
  • CAPRICOR THERAPEUTICS, INC. annual Share-based Payment Arrangement, Expense for 2022 was $4.46M, a 50.3% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

CAPRICOR THERAPEUTICS, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $15.7M $4M +$1.95M +94.9% 01 Jul 2025 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $13.7M $3.65M +$1.49M +69.4% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $12.2M $5.74M +$2.47M +75.8% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $9.77M $2.3M +$434K +23.3% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025
Q3 2024 $9.33M $2.05M +$334K +19.5% 01 Jul 2024 30 Sep 2024 10-Q 10 Nov 2025
Q2 2024 $9M $2.15M +$534K +33% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025
Q1 2024 $8.46M $3.27M +$1.07M +48.8% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $7.39M $1.86M +$713K +62.1% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025
Q3 2023 $6.68M $1.72M +$630K +58% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 $6.05M $1.62M +$461K +39.8% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $5.59M $2.19M +$1.13M +106% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 $4.46M $1.15M +$368K +47.2% 01 Oct 2022 31 Dec 2022 10-K 11 Mar 2024
Q3 2022 $4.09M $1.09M +$367K +50.9% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $3.72M $1.16M +$446K +62.6% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 $3.28M $1.07M +$312K +41.5% 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 $2.97M $780K +$306K +64.7% 01 Oct 2021 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 $2.66M $720K +$234K +48% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $2.43M $712K +$7.95K +1.13% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 $2.42M $753K +$465K +162% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q4 2020 $1.95M $474K +$345K +269% 01 Oct 2020 31 Dec 2020 10-K 11 Mar 2022
Q3 2020 $1.61M $487K +$262K +116% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 $1.35M $704K +$580K +467% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 $766K $288K +$64.6K +29% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q4 2019 $701K $128K -$252K -66.3% 01 Oct 2019 31 Dec 2019 10-K 15 Mar 2021
Q3 2019 $953K $225K -$205K -47.7% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 $1.16M $124K -$299K -70.7% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 $1.46M $223K -$212K -48.7% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 $1.67M $381K -$32.8K -7.93% 01 Oct 2018 31 Dec 2018 10-K 27 Mar 2020
Q3 2018 $1.7M $430K +$2.95K +0.69% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019
Q2 2018 $1.7M $423K +$25.1K +6.32% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019
Q1 2018 $1.67M $435K -$36.9K -7.83% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019
Q4 2017 $1.71M $413K 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 $427K 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $398K 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 $472K +$181K +62.4% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018
Q1 2016 $1.28M $291K -$282K -49.2% 01 Jan 2016 31 Mar 2016 10-Q 13 May 2016
Q4 2015 $1.56M $383K +$243K +174% 01 Oct 2015 31 Dec 2015 10-K 30 Mar 2016
Q3 2015 $1.32M $267K +$118K +79.8% 30 Jun 2015 30 Sep 2015 10-Q 13 Nov 2015
Q2 2015 $1.2M $343K +$235K +219% 01 Apr 2015 30 Jun 2015 10-Q 14 Aug 2015
Q1 2015 $968K $572K +$488K +577% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 $480K $140K +$53.7K +62.6% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 $426K $148K +$76.8K +107% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 $350K $108K +$42.9K +66.2% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 $307K $84.5K +$43.2K +104% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015
Q4 2013 $264K $85.8K +$78.4K +1052% 01 Oct 2013 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 $185K $71.6K +$20.4K +39.9% 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 $165K $64.8K -$17.4K -21.2% 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014
Q1 2013 $182K $41.4K -$130K -75.9% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 $313K $7.45K 01 Oct 2012 31 Dec 2012 10-K 21 Jun 2013
Q3 2012 $51.2K -$198K -79.4% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 $82.2K -$88.3K -51.8% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 $172K 01 Jan 2012 31 Mar 2012 10-Q 21 Jun 2013
Q3 2011 $249K 01 Jul 2011 30 Sep 2011 10-Q 21 Jun 2013
Q2 2011 $171K 01 Apr 2011 30 Jun 2011 10-Q/A 10 Sep 2012

CAPRICOR THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $9.77M +$2.37M +32.1% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025
2023 $7.39M +$2.93M +65.8% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025
2022 $4.46M +$1.49M +50.3% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2024
2021 $2.97M +$1.01M +51.9% 01 Jan 2021 31 Dec 2021 10-K 17 Mar 2023
2020 $1.95M +$1.25M +179% 01 Jan 2020 31 Dec 2020 10-K 11 Mar 2022
2019 $701K -$968K -58% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021
2018 $1.67M -$41.6K -2.43% 01 Jan 2018 31 Dec 2018 10-K 27 Mar 2020
2017 $1.71M 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2015 $1.56M +$1.08M +226% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2016
2014 $480K +$217K +82.2% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 $264K -$49.1K -15.7% 01 Jan 2013 31 Dec 2013 10-K 16 Mar 2015
2012 $313K -$473K -60.2% 01 Jan 2012 31 Dec 2012 10-K 21 Jun 2013
2011 $786K 01 Jan 2011 31 Dec 2011 10-K 21 Jun 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.